Companies/Models & infrastructure/Independent research

LabGenius Therapeutics

labgeniustx.com1 articleIndependent coverage

In the sequence

Published research

Bblueprint

LabGenius uses machine learning and functional assays to engineer antibodies

LabGenius Therapeutics explained: EVA, multi-objective antibody optimisation, preclinical programmes and the commercial structure of pharma partnerships.

Models & infrastructureThu, 29 Oct 2026

7 minread

Also in this category

All in Models & infrastructure

AbCelleraabcellera.comprofiled

Absciabsci.comprofiled

Aceracer.comprofiled

Explore related research and compare the fit for your work.

LabGenius Therapeutics

Independent company blueprint. Not affiliated with or approved by the company.

Suggest a correction →

For this company

Contribute evidence or request a correction without an account. Verify your work email to save contributions, request research and follow your requests in a private workspace. Paid services are coming soon.

For companies →